tiprankstipranks
Trending News
More News >

Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement

Story Highlights
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Clover Biopharmaceuticals Ltd. ( (HK:2197) ).

Clover Biopharmaceuticals Ltd. announced the results of its Annual General Meeting held on June 19, 2025, where all proposed resolutions were passed unanimously. The meeting also marked the retirement of a non-executive director, and the re-election of other directors, along with the appointment of a new auditor, highlighting the company’s stable governance and strategic planning.

More about Clover Biopharmaceuticals Ltd.

Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on developing innovative vaccines and biologic therapeutics, catering to global health needs.

Average Trading Volume: 1,513,917

Technical Sentiment Signal: Hold

Current Market Cap: HK$350.2M

For an in-depth examination of 2197 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1